Dracontomelon dao
Dracontomelon dao · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Dracontomelon dao is a botanical species that has garnered significant scientific interest due to its diverse therapeutic potential. Recent studies have specifically focused on the antibacterial activities inherent within its biological structures. Researchers have identified that the stem bark extracts of this plant possess unique bioactive compounds. These extracts have demonstrated promising efficacy in combating highly resistant pathogens, including MRSA. Consequently, this plant represents a valuable resource in the ongoing search for novel antimicrobial agents.
- Synonyms
- Comeurya Cumingiana · Dracontomelon Cumingianum · 14 more
- Common names
- Not available
- Family
- Anacardiaceae
- Distribution
- Europe
- Plant Parts
- Stem
Classification
Common Names
Dracontomelon dao is a versatile species known by a wide variety of regional and descriptive names. It is frequently referred to as the Argus pheasant tree or the Argus pheasant-tree in certain English-speaking contexts. In other parts of the world, the plant is commonly identified as Dahu or Lamio. Some enthusiasts also recognize it by the name Drachenapfel. These diverse monikers reflect the widespread cultural and geographical presence of this unique tree.
Sources: Catalogue of Life (COL)
Synonyms
Dracontomelon dao is a botanical species characterized by a complex web of taxonomic synonyms. Throughout various scientific studies, it has been identified by several different names, including Comeurya cumingiana and Dracontomelon brachyphyllum. The plant is also frequently referred to in literature as Dracontomelon cumingianum or Dracontomelon edule. Furthermore, the name Dracontomelon lamujo serves as another recognized synonym for this particular tree. Understanding these various nomenclatural relationships is essential for accurate identification and botanical research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dracontomelon dao is a remarkable organism belonging to the kingdom Plantae. Within this vast botanical realm, it is classified under the class Equisetopsida. This species is further organized into the order Sapindales, showcasing its specific evolutionary lineage. It serves as a distinguished member of the genus Dracontomelon. Finally, its biological identity is firmly rooted within the family Anacardiaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Anacardiaceae |
| Genus | Dracontomelon |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dracontomelon dao exhibits a widespread distribution that spans across diverse climatic zones in Asia. In temperate regions, the species is notably found throughout various parts of China, including the south-central and southeast territories. Its reach extends into tropical environments as well, where it thrives within the Indian Subcontinent, specifically across Bangladesh and the East Himalaya. Furthermore, the plant is established in the Indo-China region, with populations reaching the Andaman Islands. This broad geographic range highlights the species' remarkable ability to adapt to both temperate and tropical ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dracontomelon dao is a robust, self-supporting tree that commands attention in its natural habitat. This impressive species can reach a maximum height of 25 meters under certain conditions. However, in ideal environments, it is capable of soaring even higher to reach a maximum height of 36 meters. Its substantial growth form makes it a significant feature of the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dracontomelon dao has emerged as a promising candidate in the search for new antimicrobial compounds to combat rising drug resistance. Recent studies focusing on the stem bark extracts of this plant have demonstrated significant antibacterial activity against critical pathogens. Specifically, the extracts showed effectiveness against Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Escherichia coli. Through disc diffusion and microdilution testing, researchers determined that the extracts possess bactericidal effects. These findings suggest that D. dao holds great potential for development as a natural antibacterial agent in modern medicine.
Compounds
Conditions
Dracontomelon dao stem bark extracts demonstrate significant antibacterial activity against multidrug-resistant E. coli (MDR). The plant also effectively treats methicillin-resistant Staphylococcus aureus (MRSA), showing a measurable inhibition zone. Additionally, these extracts are sensitive to methicillin-susceptible Staphylococcus aureus (MSSA). Research indicates that the extracts possess bactericidal effects against all three bacterial types, including MRSA, MSSA, and E. coli MDR. These results highlight the potential of Dracontomelon dao as a source for developing new antibacterial agents to combat these priority pathogens.
Preparations
Dracontomelon dao is prepared as stem bark extracts to evaluate its potential medicinal properties. In this specific study, the stem bark was extracted using 60% ethanol to isolate its bioactive components. These prepared extracts were subsequently tested for their antibacterial activity against various resistant pathogens. The resulting extracts demonstrated significant effectiveness against MSSA, MRSA, and multidrug-resistant E. coli. Ultimately, the preparation of these stem bark extracts serves as a foundation for developing new antibacterial agents.
Parts used
Dracontomelon dao is a medicinal plant that shows significant promise in the fight against antibiotic-resistant pathogens. Research specifically highlights the antibacterial potential found within the plant's stem bark. By using 60% ethanol to create extracts, scientists have identified effective compounds that target both MRSA and multidrug-resistant E. coli. The study revealed that these stem extracts possess bactericidal effects, as evidenced by favorable MIC and MBC ratios. Ultimately, the stem of Dracontomelon dao serves as a vital source for developing new antibacterial agents to combat global health threats.